Evidence-Based Use of Antithrombotic Therapy
in the Prevention of Cardioembolic Stroke
Allyson Zazulia, M.D. -- Assistant Professor of Neurology and Radiology
Washington University School of Medicine -- Presented July 18, 2006


Distribution of functional outcome at 3 mo by Rx group
Ancrod compared to NINDS t-PA

95 -100
55 - 90
0 - 50
Death
placebo
35%
22%
19%
23%

Ancrod
41%
12%
20%
25%

placebo
38%
23%
18%
21%

t-PA
50%
16%
17%
17%

 

Back Next
 

 

Internet Stroke Center at Washington University:
Copyright © 1997 -2007 All rights reserved.